GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFATC1 | hg19_v2_chr18_+_77155942_77155951 | 0.09 | 1.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_153517473 Show fit | 26.54 |
ENST00000368715.1
|
S100 calcium binding protein A4 |
|
chr14_-_92413353 Show fit | 11.81 |
ENST00000556154.1
|
fibulin 5 |
|
chr6_-_32920794 Show fit | 10.06 |
ENST00000395305.3
ENST00000395303.3 ENST00000374843.4 ENST00000429234.1 |
major histocompatibility complex, class II, DM alpha Uncharacterized protein |
|
chr6_+_32407619 Show fit | 9.92 |
ENST00000395388.2
ENST00000374982.5 |
major histocompatibility complex, class II, DR alpha |
|
chr2_-_161349909 Show fit | 9.19 |
ENST00000392753.3
|
RNA binding motif, single stranded interacting protein 1 |
|
chr3_+_152017360 Show fit | 9.01 |
ENST00000485910.1
ENST00000463374.1 |
muscleblind-like splicing regulator 1 |
|
chr4_-_71532339 Show fit | 8.88 |
ENST00000254801.4
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
|
chr2_+_189839046 Show fit | 8.84 |
ENST00000304636.3
ENST00000317840.5 |
collagen, type III, alpha 1 |
|
chr3_+_151986709 Show fit | 8.77 |
ENST00000495875.2
ENST00000493459.1 ENST00000324210.5 ENST00000459747.1 |
muscleblind-like splicing regulator 1 |
|
chr1_-_226926864 Show fit | 8.36 |
ENST00000429204.1
ENST00000366784.1 |
inositol-trisphosphate 3-kinase B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 23.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
5.0 | 20.0 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.1 | 19.2 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
1.5 | 17.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.4 | 16.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.7 | 13.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.5 | 11.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 10.5 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
1.1 | 8.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.2 | 8.4 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) common myeloid progenitor cell proliferation(GO:0035726) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 20.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.8 | 17.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 17.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
1.2 | 16.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 16.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 13.6 | GO:0016604 | nuclear body(GO:0016604) |
0.9 | 10.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 10.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 8.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 8.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 31.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.3 | 26.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 18.1 | GO:0005178 | integrin binding(GO:0005178) |
5.9 | 17.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 12.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.4 | 12.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.9 | 12.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.4 | 11.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 10.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 9.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 22.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 21.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 18.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 15.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 15.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 11.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 10.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 10.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 9.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 8.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 18.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 11.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 10.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 10.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 8.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 8.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 6.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 6.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 6.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 5.8 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |